Correction to: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials
Pediatr Rheumatol Online J. 2021 Aug 16;19(1):124.
doi: 10.1186/s12969-021-00593-3.
1 Paediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Spitalstrasse 33, CH 4031, Basel, Switzerland. Tatjana.Welzel@ukbb.ch.
2 Paediatric Rheumatology, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland. Tatjana.Welzel@ukbb.ch.
3 Integrated Drug Development, Certara LP, Princeton, NJ, USA.
4 Paediatric Rheumatology, University Children's Hospital Basel (UKBB), University of Basel, Basel, Switzerland.
5 Paediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel (UKBB), University of Basel, Spitalstrasse 33, CH 4031, Basel, Switzerland.